Skip to main content
Iranian Journal of Public Health logoLink to Iranian Journal of Public Health
letter
. 2019 Jan;48(1):181–183.

The Impact of Treatment on Quality of Life in Patients with Head and Neck Cancer

Marta DĄBROWSKA-BENDER 1,2,*, Robert SŁONIEWSKI 3, Urszula RELIGIONI 4, Anna SŁONIEWSKA 5, Magdalena MILEWSKA 1, Anna KUPIECKA 2, Adrianna SOBOL 2,6, Anna STANISZEWSKA 7
PMCID: PMC6401582  PMID: 30847330

Dear Editor-in-Chief

Every year in the world there are 600,000 new cases of patients diagnosed with head and neck cancer (1,2). In Poland head and neck cancer accounts for 4.5% of all cancer cases which in 2008 reached 6046 (3). The aim of study was to assess the quality of life in patients’ treatment due to head and/or neck cancer. Study was conducted of 48 patients (52.08% men), treatment at the Oncology Center, Maria Skłodowska-Curie Institute in Warsaw, Poland, in 2015. The standardized questionnaire EORTC QLQ-C30 and QLQH&N35 module for these patients.

The study was approved by the local Ethics Committee and the management of the hospital. All subjects gave their written informed consent to participation in the study.

The mean age was 56.29±6.94 yr (range: 43–67 yr). An equal number of respondents had location of tumour: larynx and laryngopharynx and oral cavity (43.75% each) and oropharynx (12.50%). Patients was treatment: radiotherapy (54.17%); chemotherapy (4.17%); surgical treatment (2.08%); radiotherapy and chemotherapy (33.33%); surgery, radiotherapy and chemotherapy (4.17%); surgery and radiotherapy (2.08%). The mean value of subjective assessment of health condition reached 4.04±1.09 and quality of life 3.79±1.17. The statistical analysis did not reveal correlations between subjective assessment of health condition and level of quality of life and sex, age, location of tumour, stage, and type of treatment.

Each of aspects of physical function (difficulties in performing wearisome activities, fatigue during long and short walks, help required in the performance of everyday activities, limitations in the performance of everyday activities, limitations in pursuing hobbies, need for rest during the day and the sense of fatigue) was correlated with sex, age, location of tumour, stage and type of treatment. Physical function was affected solely by the stage and type of treatment. Thus, sex, age, location of tumour did not determine the physical ability of patients.

The sense of pain (dyspnoea, weakness and pain that made the performance of everyday activities more difficult) was not determined by variables: sex, age, location of tumour, stage and type of treatment.

16.7% of patients` health condition did not affect their family life, with 29.2% claimed there was no connection between their health condition and social life. Senior patients experienced significant or very significant difficulties (P=0.01).

The results of QLQ-N&H 35 questionnaire are illustrated in Table 1.

Table 1:

The results of QLQ-H&N35 questionnaire

QLQ-H&N35 N (%)
None Slight Significant Very significant
Pain in the mouth 10 (20.8) 19 (39.6) 11 (22.9) 8 (16.7)
Pain in the maxilla 13 (27.1) 19 (39.6) 10 (20.8) 6 (12.5)
Oral sensitivity 4 (8.4) 22 (45.8) 12 (25.0) 10 (20.8)
Sore throat 4 (8.4) 18 (37.5) 16 (33.3) 10 (20.8)
Difficulties in swallowing of liquids 7 (14.6) 17 (35.4) 18 (37.5) 6 (12.5)
Difficulties in swallowing of mashed foods 8 (16.7) 20 (41.7) 11 (22.9) 9 (18.7)
Difficulties in swallowing of solid foods 3 (6.3) 16 (33.3) 18 (37.5) 11 (22.9)
Choking when swallowing 13 (27.1) 12 (25.0) 13 (27.1) 10 (20.8)
Teeth problems 19 (39.6) 12(25.0) 12 (25.0) 5 (10.4)
Difficulties in mouth opening 10 (20.8) 18 (37.5) 17 (35.4) 3 (6.3)
Dry mouth 1 (2.1) 19 (39.6) 22 (45.8) 6 (12.5)
Gluey saliva 4 (8.3) 14 (29.2) 23 (47.9) 7 (14.6)
Impaired smell 7 (14.6) 22 (45.8) 12 (25.0) 7 (14.6)
Impaired taste 2 (4.2) 15 (31.3) 18 (37.5) 13 (27.1)
Cough 10 (20.8) 18 (37.5) 11 (22.9) 9 (18.8)
Hoarse voice 10 (20.8) 17 (35.4) 12 (25.0) 9 (18.8)
Feeling sick 6 (12.5) 17 (35.4) 17 (35.4) 8 (16.7)
Preoccupied with appearance 11 (22.9) 13 (27.1) 13 (27.1) 11 (22.9)
Difficulties in eating 7 (14.6) 17 (35.4) 13 (27.1) 11 (22.9)
Difficulties in eating with the family 17 (35.4) 10 (20.8) 10 (20.8) 11 (22.9)
Difficulties in eating with other people 17 (35.4) 12 (25.0) 13 (27.1) 6 (12.5)
Difficulties in deriving pleasure from eating 6 (12.5) 19 (39.6) 14 (29.2) 9 (18.8)
Difficulties in speaking with other people 12 (25.0) 17 (35.4) 11 (22.9) 8 (16.7)
Difficulties in phone conversations 8 (16.7) 20 (41.7) 10 (20.8) 10 (20.8)
Difficulties in family communication 19 (39.6) 12 (25.0) 12 (25.0) 5 (10.4)
Difficulties in social relations 16 (33.3) 16 (33.3) 11 (22.9) 5 (10.4)
Difficulties when leaving someone else’s house 17 (35.4) 14 (29.2) 9 (18.8) 8 (16.7)
Difficulties in contacts with family and friends 15 (31.3) 17 (35.4) 12 (25.0) 4 (8.3)
Decreased interest in sex 16 (33.3) 16 (33.3) 13 (27.1) 6 (12.5)
Decreased satisfaction with sex 15 (31.3) 14 (29.2) 12 (27.1) 6 (12.5)

Oral sensitivity was more common among patients completed treatment compared against those who still received treatment (P=0.04). Women reported primarily difficulties in swallowing of mashed foods (P=0.03) and impaired smell (P=0.02). A statistically significant relation was found between the sense of a dry mouth and the stage of treatment (P=0.00). The difficulties associated with phone conversations were dependent on the health condition of patients (P=0.04). The difficulties in family communication significantly impaired the quality of life of patients (P=0.01). No such relation was found in case of social relations. There was a correlation between satisfaction with sex and health condition of patients (P=0.03).

Acknowledgements

The study was not sponsored (own resources).

Footnotes

Conflict of Interests

The authors declare that there is no conflict of interest.

References

  • 1. Mehanna H, Paleri V, West CM, et al. (2011). Head and neck cancer: Epidemiology, presentation, and preservation. Clin Otolaryngol, 36: 65– 68. [DOI] [PubMed] [Google Scholar]
  • 2. Jemal A, Siegel R, Ward E, et al. (2007). Cancer statistics, 2007. CA Cancer J Clin, 57: 43– 66. [DOI] [PubMed] [Google Scholar]
  • 3. Wojciechowska U, Didkowska J, Zatoński W. (2008). Malignant neoplasms in Poland in 2008. Center of Oncology - Institute of Maria Sklodowska-Curie, Warsaw; Poland. [Google Scholar]

Articles from Iranian Journal of Public Health are provided here courtesy of Tehran University of Medical Sciences

RESOURCES